“…In previous years, the research describing the importance of systems containing benzimidazole heterocyclic system was largely multiplied and covered vast bioactive activities including antimicrobial [1][2][3], antifungal 4, anti-inflammatory [5,6 ] antihelminthic [7], antitubercular 8,9, antithrombotic; antiplatelet and anticoagulant [10], antiulcer [11], antiprotozoal 12, antileishmanial 13, anti-inflammatory 14, antiviral 15 antimycobacterial 16, anti-HIV [17], antitumour [18]. Recently, benzimidazole target was reported as an anti-hypertensive agent [19,20], potent nonnucleoside reverse transcriptase inhibitors [21], inhibitors of the hepatitis C virus [22], anticonvulsant [23], ulcerogenic [24], nonpeptide angiotensin II receptor antagonists [25], potent activators of AMPactivated protein kinase [26] and antileukemic agents 27. R.V.…”